Detalhe da pesquisa
1.
Fine-Tuning the Activation Mode of an 1,3-Indandione-Based Ruthenium(II)-Cymene Half-Sandwich Complex by Variation of Its Leaving Group.
Molecules
; 24(13)2019 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31252521
2.
Multifunctional αvß6 Integrin-Specific Peptide-Pt(IV) Conjugates for Cancer Cell Targeting.
Bioconjug Chem
; 28(9): 2429-2439, 2017 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28796473
3.
EGFR-targeting peptide-coupled platinum(IV) complexes.
J Biol Inorg Chem
; 22(4): 591-603, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405842
4.
Post-digestion stabilization of osmium enables quantification by ICP-MS in cell culture and tissue.
Analyst
; 142(13): 2327-2332, 2017 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28585637
5.
Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates.
Inorg Chem
; 56(1): 528-541, 2017 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27996251
6.
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
Angew Chem Int Ed Engl
; 56(28): 8267-8271, 2017 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28547791
7.
Modified amino-dextrans as carriers of Gd-chelates for retrograde transport and visualization of peripheral nerves by magnetic resonance imaging (MRI).
J Inorg Biochem
; 222: 111495, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34098348
8.
Investigations on the Anticancer Potential of Benzothiazole-Based Metallacycles.
Front Chem
; 8: 209, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318543
9.
MR Imaging of Peripheral Nerves Using Targeted Application of Contrast Agents: An Experimental Proof-of-Concept Study.
Front Med (Lausanne)
; 7: 613138, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33363189
10.
The antifibrotic potential of a sustained release formulation of a PDGFß-receptor targeted rho kinase inhibitor.
J Control Release
; 296: 250-257, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30682444
11.
N- and S-donor leaving groups in triazole-based ruthena(ii)cycles: potent anticancer activity, selective activation, and mode of action studies.
Dalton Trans
; 47(13): 4625-4638, 2018 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29520401
12.
Serum-binding properties of isosteric ruthenium and osmium anticancer agents elucidated by SEC-ICP-MS.
Monatsh Chem
; 149(10): 1719-1726, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30237619
13.
Bioimaging of isosteric osmium and ruthenium anticancer agents by LA-ICP-MS.
Metallomics
; 10(3): 388-396, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29513313
14.
Synthesis and in vivo anticancer evaluation of poly(organo)phosphazene-based metallodrug conjugates.
Dalton Trans
; 46(36): 12114-12124, 2017 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28862707